Portal de Periódicos da CAPES

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-Deficient Adults and Transition Patients – 2009 Update

2009; Elsevier BV; Volume: 15; Linguagem: Inglês

10.4158/ep.15.s2.1

1934-2403

David M. Cook, Kevin C.J. Yuen, Beverly M. K. Biller, Stephen F. Kemp, Mary Lee Vance, Pauline M. Camacho, Daniel S. Duick, Alan J. Garber, Jeffrey R. Garber, Hossein Gharib, Jeffrey I. Mechanick, Steven M. Petak, David M. Cook, Kevin C.J. Yuen, Beverly M. K. Biller, Stephen F. Kemp, Mary Lee Vance,

Sexual Differentiation and Disorders

For adults, proven benefits of recombinant human growth hormone (GH) replacement therapy have been demonstrated in those with GH deficiency (GHD) (1 [EL 2], 2 [EL 2], 3 [EL 1], 4 [EL 2]). This has resulted in its expanding use in clinical endocrine practice. GH has also been misused in recent years in certain factions of the sporting world because of its increased availability (5 [EL 3], 6 [EL 3]) and has been touted in the media as a formula for the "fountain of youth" for the elderly population (7 [EL 4], 8 [EL 4]).